News Highly Sensitive to Stock Price 27 Jan 2026

Kirloskar Pneumatic: Standalone revenue stood at Rs 404 crore, registering a growth of 18.6% year-on-year. EBITDA increased by 66% year-on-year to Rs 80.7 crore, while EBITDA margin improved to 20% in Q3FY26 from 14.3% in Q3FY25. Net profit for the quarter stood at Rs 43.1 crore compared to Rs 36 crore in the same quarter last year, reflecting a growth of 19.4%. The company’s order book stood at around Rs 1,939 crore as on 1 January 2026, compared to Rs 1,624 crore as on 1 April 2025.

Granules India: Total revenue for the quarter grew 22% year-on-year to Rs 1,388 crore. EBITDA rose 34% year-on-year to Rs 230.3 crore, with operating margin expanding by 200 basis points to 22.2%. Net profit increased 28% year-on-year to Rs 150.2 crore. R&D expenses stood at Rs 69 crore, accounting for 5% of sales in Q3FY26, compared to Rs 70.5 crore or 5.4% of sales in Q2FY26. For 9MFY26, R&D expenses were Rs 208 crore, representing 5.4% of sales. Net debt stood at Rs 1,015 crore, with net debt to EBITDA at 0.91x. Finished dosage formulations revenue increased 22% year-on-year to Rs 1,056 crore, while the pharma formulation intermediates business grew 13% to Rs 148 crore. API sales grew 9% year-on-year to Rs 151.5 crore. EPS for the quarter stood at Rs 6.2, while EPS for 9MFY26 was Rs 16.2.

Chennai Petroleum Corporation: For the quarter ended December 31, 2025, total revenue from operations stood at Rs 19,438 crore, compared to Rs 15,683 crore in the corresponding quarter last year. The company reported a profit before tax of Rs 1,317 crore and a profit after tax of Rs 987 crore, against a profit before tax of Rs 14 crore and profit after tax of Rs 10 crore in the same period last year. Finance cost declined to Rs 32.7 crore from Rs 79.2 crore a year ago. Gross refining margin for the quarter improved to US$ 10.97 per barrel compared to US$ 4.29 per barrel in the same period last year.

Godrej Consumer: Revenue for the quarter stood at Rs 4,099 crore. On a year-on-year basis, revenue rose 8.8% from Rs 3,768.4 crore in the corresponding quarter last year. EBITDA for the quarter came in at Rs 880.5 crore, increasing 16.4% year-on-year from Rs 756 crore. EBITDA margin for the quarter stood at 21.5%, compared to 20.1% in the same period last year.

Waaree Renewables: Waaree Renewable Technologies Limited will enter into a binding term sheet for the acquisition of approximately 55% stake in the equity share capital of Associated Power Structures Limited for a total consideration of Rs 1,225 crore. Associated Power Structures Limited, established in 1996, operates in the power transmission and distribution infrastructure segment. Following the acquisition of shares, Associated Power Structures Limited will become a subsidiary of the company.

JSW Energy: Operational revenue increased 67.4% year-on-year to Rs 4,081.8 crore, though it declined 21.2% quarter-on-quarter. EBITDA rose 122.1% year-on-year but declined 32.3% quarter-on-quarter to Rs 2,029.57 crore, primarily driven by contributions from acquired assets including the Mahandi thermal plant and O2 portfolio. EBITDA margins stood at 49.7% compared to 37.5% in Q3FY25. Q3 FY26 reported profit after tax improved 150.2% year-on-year mainly due to deferred tax reversal but declined 40.4% quarter-on-quarter to Rs 528.8 crore.

Shyam Metalics & Energy: The company reported revenue of Rs 4,421 crore, up 17% year-on-year but down 1% quarter-on-quarter. Operating profit stood at Rs 487 crore with an operating margin of 11%. Net profit stood at Rs 198 crore, up 1% year-on-year but down 24% quarter-on-quarter.

Torrent Pharmaceuticals: The US FDA inspected the company’s Dahej manufacturing facility from 19 January 2026 to 23 January 2026. The inspection has been concluded with zero observations.

Zydus Lifesciences: The US FDA conducted an inspection at the group’s Unit 2 manufacturing plant at Ankleshwar, Gujarat. The inspection was carried out from 19 January to 23 January 2026 and concluded with three observations. There were no data integrity-related observations.

IFB Industries: Revenue increased 11.3% to Rs 1,413 crore. EBITDA declined 14.2% to Rs 76.4 crore, while operating margin stood at 5.4%. Net profit declined 22.6% to Rs 24 crore compared to Rs 31 crore earlier.

UltraTech Cement: UltraTech Cement reported revenue of Rs 21,830 crore, up 23% year-on-year and 11% quarter-on-quarter. The company reported operating profit of Rs 3,911 crore with a margin of 18%. Net profit stood at Rs 1,729 crore, up 27% year-on-year and 40% quarter-on-quarter. Consolidated cement sales volumes recorded a growth of 15% year-on-year.

HG Infra: Four officials of the company, namely Mr Anoop Singh, Mr Gaurav Kushwaha, Mr Akash Patra and Mr Dhiraj Virmani, have been taken into custody by the Central Bureau of Investigation (CBI). However, the CBI has not shared the FIR or other necessary details with the company. The company is examining the matter, evaluating appropriate legal steps and will inform the stock exchanges accordingly.

Bharat Petroleum Corp Ltd (BPCL) Q3FY26 result review: BPCL’s numbers were above expectations in Q3FY26. The company’s standalone revenue from operations rose about 5.2% to Rs 118,999 crore, while reported net profit stood at Rs 7,545 crore compared to Rs 4,650 crore in Q3FY25. Operating margin improved to 9.8% from 6.7% in Q3FY25. The average gross refining margin for the nine months ended 31 December 2025 stood at $9.68 per barrel, compared to $5.95 per barrel in the April to December 2024 period.

Telecom: The Telecom Regulatory Authority of India (TRAI) plans to review tariffs for domestic leased circuits for the first time in over a decade. Domestic leased circuits are dedicated high-speed data lines used by banks, government offices, hospitals, data centres and large companies to ensure secure and reliable internet connections.

Oil and Gas: India’s crude oil sourcing strategy has shown a clear shift towards lower-risk and more execution-reliable supply. Middle Eastern barrels have gained share, while Russian crude flows remain present but are increasingly selective and compliance-driven.

Reliance Industries: India’s Russian crude oil imports saw a slight dip in early January, with Reliance Industries halting purchases while state-run refiners such as IOC and BPCL increased intake to attract discounts. Nayara Energy continued its significant sourcing through intermediaries. Overall volumes remain lower than late 2025 levels, influenced by US sanctions on major Russian exporters.

Atul Ltd: Overall numbers were in line with expectations for the quarter. Revenue increased 11% year-on-year to Rs 1,573.6 crore against an estimate of Rs 1,545 crore. Operating margin contracted 10 basis points year-on-year to 15.7%, compared to an expectation of 16%. Net profit rose 47.8% year-on-year to Rs 160.7 crore. Other income surged 144% year-on-year to Rs 38.6 crore. The company reported a one-off provision of Rs 41.4 crore during the quarter. EPS for the quarter stood at Rs 54.6, while EPS for 9MFY26 was Rs 159. At the current market price, the stock trades at 22x FY28E EPS.

Axis Bank: Axis Bank reported a 3% year-on-year increase in net profit to Rs 6,490 crore. Net interest income grew 5% year-on-year to Rs 14,286 crore. NIM and cost of funds stood at 3.64% and 5.07% respectively, compared with 3.73% and 5.15% in Q2FY26. Asset quality improved on a sequential basis, with gross NPA at 1.40% compared to 1.46% in the September quarter. Net NPA eased to 0.42% from 0.44% quarter-on-quarter. Total advances grew 14% year-on-year to Rs 11.6 lakh crore.

Kotak Mahindra Bank: Kotak Mahindra Bank reported a robust performance in Q3FY26, with standalone net profit rising 4% year-on-year to Rs 3,446 crore. The growth was supported by a 5% increase in net interest income to Rs 7,565 crore, indicating healthy expansion in core lending operations. Net interest margin remained steady at 4.54%. Gross NPA improved to 1.30% from 1.39% in Q2FY26, while net NPA remained unchanged at 0.31%. Total advances grew 15.4% year-on-year to Rs 5.0 lakh crore.

Shriram Finance: Net interest income increased 17.9% year-on-year to Rs 6,574 crore, while net profit grew 22.1% to Rs 2,522 crore. Assets under management rose 14.6% year-on-year to Rs 2.9 lakh crore as on December 31, 2025. Asset quality showed marginal improvement during the December quarter, with gross NPA easing to 4.54% from 4.57% in the previous quarter. Net NPA declined to 2.38% from 2.49% on a quarter-on-quarter basis.

Multi Commodity Exchange (MCX): MCX reported a 151% year-on-year growth in consolidated profit after tax to Rs 401 crore in Q3FY26. Revenue from operations for the quarter stood at Rs 666 crore, marking a growth of 121% year-on-year. EBITDA rose 156.5% year-on-year to Rs 495.1 crore. Average daily turnover of futures and options for Q3FY26 increased 224% year-on-year to Rs 7,50,136 crore from Rs 2,31,821 crore. The bullion segment’s share in average daily turnover increased to 69% quarter-on-quarter, supported by the launch of new variants including Gold Mini and Gold Ten Futures.

OneSource Specialty: Revenue stood at Rs 290.3 crore, declining 26% year-on-year, impacted by delayed Semaglutide approvals in Canada. EBITDA declined sharply by 88% year-on-year to Rs 17.5 crore. The company reported a net loss of Rs 88.7 crore compared to a net loss of Rs 69 crore in Q3FY25. Finance cost declined 16.5% year-on-year to Rs 38.3 crore. The company reaffirmed its FY28 guidance of $400 million in organic revenue and $500 million including the recently proposed acquisition, with an EBITDA margin of around 40%.

Gravita India: Gravita India Limited announced the launch of its lithium-ion battery recycling plant in Mundra, Gujarat, with a capacity of 6,000 MTPA. The company has invested approximately Rs 14 crore towards the procurement and commissioning of the recycling plant.

JSW Steel: JSW Steel reported revenue of Rs 45,991 crore, up 11% year-on-year and 2% quarter-on-quarter. The company reported operating profit of Rs 6,379 crore with an operating margin of 14%. Net profit stood at Rs 2,139 crore compared with Rs 717 crore in Q3FY25. A one-time exceptional item of Rs 529 crore was reported during the quarter.

Akums Drugs: Akums Drugs and Pharmaceuticals Limited has received European GMP certifications for its two facilities, Plant 1 and Plant 2, both located at Haridwar, Uttarakhand. The certification for Plant 1 represents a renewal of its existing EU-GMP approval, while Plant 2 has received EU-GMP certification for the first time. The European CDMO contract signed by Akums in December 2024 will be serviced from Plant 2.

Cipla: Overall performance was weak during the quarter, with total revenue remaining flat year-on-year at Rs 7,074.5 crore, compared with an estimate of Rs 7,225 crore. Operating margin declined by 1,040 basis points year-on-year to 17.7% versus an expected 22%. Other expenses rose 14.8% year-on-year to Rs 1,862 crore. Net profit declined 57% year-on-year to Rs 675.8 crore, while other income fell 7% year-on-year to Rs 206.3 crore. The company reported a one-off provision of Rs 276 crore related to the new labour code during the quarter. Domestic formulation sales increased around 10% year-on-year to Rs 3,457 crore, while the branded prescription business delivered a 10% year-on-year growth. US sales declined 22% year-on-year to Rs 1,485 crore. The company is targeting four respiratory launches in the US by FY27. Net cash and equivalents stood at Rs 10,200 crore as of December 2025. EPS for the quarter was Rs 8.36, while EPS for 9MFY26 was Rs 41.1. At the current market price, the stock trades at 21x FY28E EPS.

Laurus Labs: Laurus Labs reported numbers better than expectations for the quarter, with total revenue increasing 25.7% year-on-year to Rs 1,778 crore compared with an estimate of Rs 1,692 crore. Operating margin expanded by 680 basis points year-on-year to 27% versus an expected 25%, while gross margin improved by 400 basis points year-on-year to 60.9%. Net profit surged 171.2% year-on-year to Rs 251.7 crore. Finance cost declined 33% year-on-year to Rs 39 crore. API sales grew 36% year-on-year and 17% quarter-on-quarter to Rs 720 crore, while the formulation business reported a 39% year-on-year growth to Rs 607 crore. CDMO synthesis revenue increased 1% year-on-year to Rs 451 crore. R&D expenses stood at Rs 206 crore, accounting for 4.1% of sales for 9MFY26, while capex for 9MFY26 stood at Rs 735 crore. EPS for the quarter stood at Rs 4.65 and EPS for 9MFY26 was Rs 11.3. At the current market price, the stock trades at 44.5x FY28E EPS.

Source: HSL Prime Daily, 27 Jan 2026

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.  

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.  

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations